Allison R.  Eberly, PhD

Allison R. Eberly, PhD

Assistant Professor, Pathology & Immunology

Division

  • Laboratory & Genomic Medicine

Additional Titles

  • Medical Director of Pre-analytical Microbiology and Outreach, Barnes-Jewish Hospital
  • Medical Director of Mycobacteriology and Sexual Health Molecular Diagnostics, Barnes-Jewish Hospital
  • Microbiology Laboratory Liaison, Memorial Hospital Belleville & Shiloh, Alton Memorial Hospital, Christian Hospital, and Parkland Hospital

Education

  • BS: Chemistry and Molecular Biology, Chestnut Hill College, Philadelphia, PA (2014)
  • PhD: Microbiology and Immunology, Vanderbilt University, Nashville, TN (2019)
  • Fellowship, Clinical Microbiology: Mayo Clinic, Rochester, MN (2021)

Board Certifications

  • Diplomate, American Board of Medical Microbiology, 2021

Clincal Interests

  • Microbiology
  • Molecular infectious disease diagnostics
  • Nontuberculous mycobacteria (NTM)
  • Sexually transmitted infections (STIs)
  • Pre-analytical microbiology and outreach

Research Interests

My research interests include developing and implementing more rapid and accurate diagnostic tests for infections that are under-/mis-diagnosed. I am particularly interested in molecular diagnostics for nontuberculous mycobacteria (NTM) and improving access to STI molecular testing, including HPV.

Selected Publications

Rodino KG, Luethy PM, Abbott AN, Bender JM, Eberly AR, Gitman M, Leber A, Dien Bard J; Personnel Standards and Workforce Subcommittee, American Society for Microbiology. Defining the value of medical microbiology consultation. J Clin Microbiol. 2024 Jun 21:e0035924. doi: 10.1128/jcm.00359-24. Epub ahead of print. PMID: 38904385
Core Genome Multilocus Sequence Typing and Antibiotic Susceptibility Prediction from Whole-Genome Sequence Data of Multidrug-Resistant Pseudomonas aeruginosa Isolates. Cunningham SA, Eberly AR, Beisken S, Posch AE, Schuetz AN, Patel R. Microbiol Spectr. 2022 Dec 21;10(6):e0392022. doi: 10.1128/spectrum.03920-22. Epub 2022 Nov 9. PMID: 36350158
Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis. Eberly AR, Wallace MA, Shannon S, Heitman AK, Schuetz AN, Burnham CD, Jean S. J Clin Microbiol. 2022 Apr 20;60(4):e0218821. doi: 10.1128/jcm.02188-21. Epub 2022 Mar 22. PMID: 35313739
Understanding and Application of Daptomycin-Susceptible Dose-Dependent Category for Enterococcus: A Mixed-Methods Study. Adema JL, Lake LN, Stevens RW, Hogan BM, Schuetz AN, Tande AJ, Mara KC, Eberly AR, Rivera CG. Open Forum Infect Dis. 2022 Jan 10;9(1):ofab611. doi: 10.1093/ofid/ofab611. eCollection 2022 Jan. PMID: 35036465
Performance of three polymerase chain reaction-based assays for detection of SARS-CoV-2 in different upper respiratory tract specimens. Eberly AR, Germer JJ, Boerger AC, Fernholz EC, Binnicker MJ, Yao JD.
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115441. doi: 10.1016/j.diagmicrobio.2021.115441. Epub 2021 May 28. PMID: 34186320

Assistant
Shelley Cuervo
314-362-2207
cuervo@wustl.edu
IOH Room 5800